Transforming growth factor-beta and the glomerular filtration barrier

Kidney Research and Clinical Practice

Volumn 32, Issue 1, 2013, Pages 3-10

  Ghayur, Ayesha ^a   Margetts, Peter J ^a  

^a ST JOSEPH S HOSPITAL   (Canada)

Author keywords

Angiopoietin; Glomerular endothelial cell; Podocyte; Proteinuria; Transforming growth factor beta

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; BETA CATENIN; CONNECTIVE TISSUE GROWTH FACTOR; FG 3019; MICRORNA; NOTCH RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; VASCULOTROPIN;

ALBUMINURIA; APOPTOSIS; CELL DEDIFFERENTIATION; CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; GLOMERULAR FILTRATION BARRIER; GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; HUMAN; KIDNEY FIBROSIS; MESANGIUM CELL; NONHUMAN; PARACRINE SIGNALING; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; REVIEW; WNT SIGNALING PATHWAY;

EID: 84879193907     PISSN: 22119132     EISSN: 22119140     Source Type: Journal    
DOI: 10.1016/j.krcp.2013.01.003     Document Type: Review

References (102)

1. P Ruggenenti, A Schieppati, and G Remuzzi Progression, remission, regression of chronic renal diseases Lancet 357 2001 1601 1608
2. BR Hemmelgarn, BJ Manns, A Lloyd, MT James, S Klarenbach, RR Quinn, N Wiebe, and M Tonelli Relation between kidney function, proteinuria, and adverse outcomes JAMA 303 2010 423 429
3. MR Lattanzio, and MR Weir Does blockade of the renin-angiotensin- aldosterone system slow progression of all forms of kidney disease? Curr Hypertens Rep 12 2010 369 377
4. L Gnudi Molecular mechanisms of proteinuria in diabetes Biochem Soc Trans 36 2008 946 949
5. J Ly, M Alexander, and SE Quaggin A podocentric view of nephrology Curr Opin Nephrol Hypertens 13 2004 299 305
6. K Tryggvason, J Patrakka, and J Wartiovaara Hereditary proteinuria syndromes and mechanisms of proteinuria N Engl J Med 354 2006 1387 1401
7. G Wolf, and FN Ziyadeh Cellular and molecular mechanisms of proteinuria in diabetic nephropathy Nephron Physiol 106 2007 26 31
8. Y Li, YS Kang, C Dai, LP Kiss, X Wen, and Y Liu Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria Am J Pathol 172 2008 299 308
9. G Remuzzi, P Ruggenenti, and A Benigni Understanding the nature of renal disease progression Kidney Int 51 1997 2 15
10. M Abbate, C Zoja, D Rottoli, D Corna, S Tomasoni, and G Remuzzi Proximal tubular cells promote fibrogenesis by TGF-beta1-mediated induction of peritubular myofibroblasts Kidney Int 61 2002 2066 2077
11. AF Castro, and J Coresh CKD surveillance using laboratory data from the population-based National Health and Nutrition Examination Survey (NHANES) Am J Kidney Dis 53 2009 S46 S55
12. N Perico, A Benigni, and G Remuzzi Nat Rev Drug Discov Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection 7 2008 936 953
13. R Hirschberg, and S Wang Proteinuria and growth factors in the development of tubulointerstitial injury and scarring in kidney disease Curr Opin Nephrol Hypertens 14 2005 43 52
14. W Kriz, and M LeHir Pathways to nephron loss starting from glomerular diseases-insights from animal models Kidney Int 67 2005 404 419
15. M Abbate, C Zoja, and G Remuzzi How does proteinuria cause progressive renal damage? J Am Soc Nephrol 17 2006 2974 2984
16. WD Comper, LM Hilliard, DJ Nikolic-Paterson, and LM Russo Disease-dependent mechanisms of albuminuria Am J Physiol Renal Physiol 295 2008 F1589 F1600
17. SX Wang, MP Rastaldi, A Patari, H Ahola, E Heikkila, and H Holthofer Patterns of nephrin and a new proteinuria-associated protein expression in human renal diseases Kidney Int 61 2002 141 147
18. A Patari, and C Forsblom Havana M, Taipale H, Groop PH, Holthofer H: Nephrinuria in diabetic nephropathy of type 1 diabetes Diabetes 52 2003 2969 2974
19. EJ Weil, KV Lemley, CC Mason, B Yee, LI Jones, K Blouch, T Lovato, M Richardson, BD Myers, and RG Nelson Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy Kidney Int 82 2012 1010 1017
20. M Camici Urinary detection of podocyte injury Biomed Pharmacother 61 2007 245 249
21. S Menini, C Iacobini, G Oddi, C Ricci, P Simonelli, S Fallucca, M Grattarola, F Pugliese, C Pesce, and G Pugliese Increased glomerular cell (podocyte) apoptosis in rats with streptozotocin-induced diabetes mellitus: role in the development of diabetic glomerular disease Diabetologia 50 2007 2591 2599
22. V Eremina, M Sood, J Haigh, A Nagy, G Lajoie, N Ferrara, HP Gerber, Y Kikkawa, JH Miner, and SE Quaggin Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases J Clin Invest 111 2003 707 716
23. V Eremina, JA Jefferson, J Kowalewska, H Hochster, M Haas, J Weisstuch, C Richardson, JB Kopp, MG Kabir, PH Backx, HP Gerber, N Ferrara, L Barisoni, CE Alpers, and SE Quaggin VEGF inhibition and renal thrombotic microangiopathy N Engl J Med 358 2008 1129 1136
24. A Advani, and RE Gilbert The endothelium in diabetic nephropathy Semin Nephrol 32 2012 199 207
25. ZD Li, JP Bork, B Krueger, E Patsenker, A Schulze-Krebs, EG Hahn, and D Schuppan VEGF induces proliferation, migration, and TGF-beta1 expression in mouse glomerular endothelial cells via mitogen-activated protein kinase and phosphatidylinositol 3-kinase Biochem Biophys Res Commun 334 2005 1049 1060
26. SC Satchell, KL Anderson, and PW Mathieson Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties J Am Soc Nephrol 15 2004 566 574
27. B Davis, A Dei Cas, DA Long, KE White, A Hayward, CH Ku, AS Woolf, R Bilous, G Viberti, and L Gnudi Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular endothelia J Am Soc Nephrol 18 2007 2320 2329
28. D Wu, F Peng, B Zhang, AJ Ingram, B Gao, and JC Krepinsky Collagen I induction by high glucose levels is mediated by epidermal growth factor receptor and phosphoinositide 3-kinase/Akt signaling in mesangial cells Diabetologia 50 2007 2008 2018
29. KN Lai, JC Leung, LY Chan, MA Saleem, PW Mathieson, KY Tam, J Xiao, FM Lai, and SC Tang Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy Nephrol Dial Transplant 24 2008 62 72
30. S Khan, S Lakhe-Reddy, JH McCarty, CM Sorenson, N Sheibani, LF Reichardt, JH Kim, B Wang, JR Sedor, and JR Schelling Mesangial cell integrin alphavbeta8 provides glomerular endothelial cell cytoprotection by sequestering TGF-beta and regulating PECAM-1 Am J Pathol 178 2011 609 620
31. M Ding, S Cui, C Li, S Jothy, V Haase, BM Steer, PA Marsden, J Pippin, S Shankland, MP Rastaldi, CD Cohen, M Kretzler, and SE Quaggin Loss of the tumor suppressor Vhlh leads to upregulation of Cxcr4 and rapidly progressive glomerulonephritis in mice Nat Med 12 2006 1081 1087
32. CA Chen, JC Hwang, JY Guh, JM Chang, YH Lai, and HC Chen Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats J Lab Clin Med 147 2006 74 82
33. U Fiedler, and HG Augustin Angiopoietins: a link between angiogenesis and inflammation Trends Immunol 27 2006 552 558
34. A Papapetropoulos, D Fulton, K Mahboubi, RG Kalb, DS O'Connor, F Li, DC Altieri, and WC Sessa Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway J Biol Chem 275 2000 9102 9105
35. PC Maisonpierre, C Suri, PF Jones, S Bartunkova, SJ Wiegand, C Radziejewski, D Compton, J McClain, TH Aldrich, N Papadopoulos, TJ Daly, S Davis, TN Sato, and GD Yancopoulos Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis Science 277 1997 55 60
36. P Kumpers, S David, M Haubitz, J Hellpap, R Horn, V Brocker, M Schiffer, H Haller, and T Witte The Tie2 receptor antagonist angiopoietin-2 facilitates vascular inflammation in systemic lupus erythematosus Ann Rheum Dis 68 2008 1638 1643
37. A Ghayur, L Liu, M Kolb, A Chawla, S Lambe, A Kapoor, and PJ Margetts Adenovirus-mediated gene transfer of TGF-beta1 to the renal glomeruli leads to proteinuria Am J Pathol 180 2012 940 951
38. V Campean, B Karpe, C Haas, A Atalla, H Peters, H Rupprecht, S Liebner, T Acker, K Plate, and K Amann Angiopoietin 1 and 2 gene and protein expression is differentially regulated in acute anti-Thy1.1 glomerulonephritis Am J Physiol Renal Physiol 294 2008 F1174 F1184
39. JE De Larco, and GJ Todaro Growth factors from murine sarcoma virus-transformed cells Proc Natl Acad Sci U S A 75 1978 4001 4005
40. K Ask, P Bonniaud, K Maass, O Eickelberg, PJ Margetts, D Warburton, J Groffen, J Gauldie, and M Kolb Progressive pulmonary fibrosis is mediated by TGF-beta isoform 1 but not TGF-beta3 Int J Biochem Cell Biol 40 2008 484 495
41. G Jenkins The role of proteases in transforming growth factor-beta activation Int J Biochem Cell Biol 40 2008 1068 1078
42. A Pozzi, and R Zent TGF-beta sequestration by mesangial cell integrin alphavbeta8: A novel mechanism of glomerular endothelial cell regulation Am J Pathol 178 2011 485 489
43. JP Annes, JS Munger, and DB Rifkin Making sense of latent TGFbeta activation J Cell Sci 116 2003 217 224
44. P Patel, Y Sekiguchi, KH Oh, SE Patterson, MR Kolb, and PJ Margetts Smad3-dependent and -independent pathways are involved in peritoneal membrane injury Kidney Int 77 2010 319 328
45. G Gambaro, C Weigert, M Ceol, and ED Schleicher Inhibition of transforming growth factor-beta 1 gene overexpression as a strategy to prevent fibrosis. [Review] [36 refs] Contrib Nephrol 131 2001 107 113
46. G Wolf Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway Kidney Int 70 2006 1914 1919
47. AA Eddy, and CM Giachelli Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria Kidney Int 47 1995 1546 1557
48. L Gunaratnam, M Morley, A Franovic, N de Paulsen, K Mekhail, DA Parolin, E Nakamura, IA Lorimer, and S. Lee Hypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL(-/-) renal cell carcinoma cells J Biol Chem 278 2003 44966 44974
49. BD Humphreys, SL Lin, A Kobayashi, TE Hudson, BT Nowlin, JV Bonventre, MT Valerius, AP McMahon, and JS Duffield Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis Am J Pathol 176 2010 85 97
50. M Zeisberg, J Hanai, H Sugimoto, T Mammoto, D Charytan, F Strutz, and R Kalluri BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury Nat Med 9 2003 964 968
51. Park JS, Jo CH, Kim S, Kim GH: Acute and chronic effects of dietary sodium restriction on renal tubulointerstitial fibrosis in cisplatin-treated rats. Nephrol Dial Transplant, 2012, Nov 4. [Epub ahead of print]
52. EP Bottinger TGF-beta in renal injury and disease Semin Nephrol 27 2007 309 320
53. WA Border, and NA Noble TGF-beta in kidney fibrosis: a target for gene therapy Kidney Int 51 1997 1388 1396
54. DS Goumenos, S Tsakas, AM el Nahas, S Alexandri, S Oldroyd, P Kalliakmani, and JG Vlachojannis Transforming growth factor-beta(1) in the kidney and urine of patients with glomerular disease and proteinuria Nephrol Dial Transplant 17 2002 2145 2152
55. CC Hou, W Wang, XR Huang, P Fu, TH Chen, D Sheikh-Hamad, and HY Lan Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney Am J Pathol 166 2005 761 771
56. SM Ka, XR Huang, HY Lan, PY Tsai, SM Yang, HA Shui, and A Chen Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice J Am Soc Nephrol 18 2007 1777 1788
57. Y Saegusa, C Sadakane, J Koseki, Y Hasegawa, S Shindo, H Maruyama, S Takeda, H Takeda, and T Hattori TJN-331 improves anti-glomerular basement membrane nephritis by inhibiting the production of intraglomerular transforming growth factor-beta1 Biol Pharm Bull 33 2010 1349 1354
58. JB Kopp, VM Factor, M Mozes, P Nagy, N Sanderson, EP Böttinger, PE Klotman, and SS Thorgeirsson Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease Lab Invest 74 1996 991 1003
59. S Krag, R Osterby, Q Chai, CB Nielsen, C Hermans, and L Wogensen TGF-beta1-induced glomerular disorder is associated with impaired concentrating ability mimicking primary glomerular disease with renal failure in man Lab Invest 80 2000 1855 1868
60. D Wang, C Dai, Y Li, and Y Liu Canonical Wnt/beta-catenin signaling mediates transforming growth factor-beta1-driven podocyte injury and proteinuria Kidney Int 80 2011 1159 1169
61. K Tryggvason Unraveling the mechanisms of glomerular ultrafiltration: nephrin, a key component of the slit diaphragm J Am Soc Nephrol 10 1999 2440 2445
62. CE Patek, S Fleming, CG Miles, CO Bellamy, M Ladomery, L Spraggon, J Mullins, ND Hastie, and ML Hooper Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis Hum Mol Genet 12 2003 2379 2394
63. R Sam, L Wanna, KP Gudehithlu, SL Garber, G Dunea, JA Arruda, and AK Singh Glomerular epithelial cells transform to myofibroblasts: early but not late removal of TGF-beta1 reverses transformation Transl Res 148 2006 142 148
64. PL Tharaux, and TB Huber How many ways can a podocyte die? Semin Nephrol 32 2012 394 404
65. M Herman-Edelstein, MC Thomas, V Thallas-Bonke, M Saleem, ME Cooper, and P Kantharidis Dedifferentiation of immortalized human podocytes in response to transforming growth factor-beta: a model for diabetic podocytopathy Diabetes 60 2011 1779 1788
66. MA Nieto The snail superfamily of zinc-finger transcription factors Nat Rev Mol Cell Biol 3 2002 155 166
67. I Matsui, T Ito, H Kurihara, E Imai, T Ogihara, and M Hori Snail, a transcriptional regulator, represses nephrin expression in glomerular epithelial cells of nephrotic rats Lab Invest 87 2007 273 283
68. M Godel, B Hartleben, N Herbach, S Liu, S Zschiedrich, S Lu, A Debreczeni-Mór, MT Lindenmeyer, MP Rastaldi, G Hartleben, T Wiech, A Fornoni, RG Nelson, M Kretzler, R Wanke, H Pavenstädt, D Kerjaschki, CD Cohen, MN Hall, MA Rüegg, K Inoki, G Walz, and TB Huber Role of mTOR in podocyte function and diabetic nephropathy in humans and mice J Clin Invest 121 2011 2197 2209
69. K Inoki, H Mori, J Wang, T Suzuki, S Hong, S Yoshida, SM Blattner, T Ikenoue, MA Rüegg, MN Hall, DJ Kwiatkowski, MP Rastaldi, TB Huber, M Kretzler, LB Holzman, RC Wiggins, and KL Guan mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice J Clin Invest 121 2011 2181 2196
70. KM Boini, K Amann, D Kempe, DR Alessi, and F Lang Proteinuria in mice expressing PKB/SGK-resistant GSK3 Am J Physiol Renal Physiol 296 2009 F153 F159
71. H Kato, A Gruenwald, JH Suh, JH Miner, L Barisoni-Thomas, MM Taketo, C Faul, SE Millar, LB Holzman, and K Susztak Wnt/{beta}-catenin pathway in podocytes integrates cell adhesion, differentiation, and survival J Biol Chem 286 2011 26003 26015
72. YS Kang, Y Li, C Dai, LP Kiss, C Wu, and Y Liu Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria Kidney Int 78 2010 363 373
73. M Murea, JK Park, S Sharma, H Kato, A Gruenwald, T Niranjan, H Si, DB Thomas, JM Pullman, ML Melamed, and K Susztak Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function Kidney Int 78 2010 514 522
74. C Wang, X Liu, Z Ke, Y Tang, CC Li, CM Li, Z Ye, J Zhang, and T Lou Mesangial medium from IgA nephropathy patients induces podocyte epithelial-to-mesenchymal transition through activation of the phosphatidyl inositol-3-kinase/Akt signaling pathway Cell Physiol Biochem 29 2012 743 752
75. G Finer, HW Schnaper, YS Kanwar, X Liang, HY Lin, and T Hayashida Divergent roles of Smad3 and PI3-kinase in murine adriamycin nephropathy indicate distinct mechanisms of proteinuria and fibrogenesis Kidney Int 82 2012 525 536
76. H Kato, and K Susztak Repair problems in podocytes: Wnt, Notch, and glomerulosclerosis Semin Nephrol 32 2012 350 356
77. T Niranjan, B Bielesz, A Gruenwald, MP Ponda, JB Kopp, DB Thomas, and K Susztak The Notch pathway in podocytes plays a role in the development of glomerular disease Nat Med 14 2008 290 298
78. P Patel, Y Sekiguchi, KH Oh, SE Patterson, MR Kolb, and PJ Margetts Smad3-dependent and -independent pathways are involved in peritoneal membrane injury Kidney Int 77 2010 319 328
79. A Wang, FN Ziyadeh, EY Lee, PE Pyagay, SH Sung, SA Sheardown, NJ Laping, and S Chen Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria Am J Physiol Renal Physiol 293 2007 F1657 F1665
80. Y Yamaguchi, M Iwano, D Suzuki, K Nakatani, K Kimura, K Harada, A Kubo, Y Akai, M Toyoda, M Kanauchi, EG Neilson, and Y Saito Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy Am J Kidney Dis 54 2009 653 664
81. L De Petris, KA Hruska, S Chiechio, and H Liapis Bone morphogenetic protein-7 delays podocyte injury due to high glucose Nephrol Dial Transplant 22 2007 3442 3450
82. C Hjalmarsson, BR Johansson, and B Haraldsson Electron microscopic evaluation of the endothelial surface layer of glomerular capillaries Microvasc Res 67 2004 9 17
83. M Nieuwdorp, HL Mooij, J Kroon, B Atasever, JA Spaan, C Ince, F Holleman, M Diamant, RJ Heine, JB Hoekstra, JJ Kastelein, ES Stroes, and H Vink Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes Diabetes 55 2006 1127 1132
84. SC Satchell The glomerular endothelium emerges as a key player in diabetic nephropathy Kidney Int 82 2012 949 951
85. HS El-Banawy, EW Gaber, DA Maharem, and KA Matrawy Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus J Nephrol 25 2012 541 550
86. LA van Meeteren, and P ten Dijke Regulation of endothelial cell plasticity by TGF-beta Cell Tissue Res 347 2012 177 186
87. EM Zeisberg, SE Potenta, H Sugimoto, M Zeisberg, and R Kalluri Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition J Am Soc Nephrol 19 2008 2282 2287
88. J Li, X Qu, and JF Bertram Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice Am J Pathol 175 2009 1380 1388
89. JH Miner Glomerular basement membrane composition and the filtration barrier Pediatr Nephrol 26 2011 1413 1417
90. ML Caramori, Y Kim, C Huang, AJ Fish, SS Rich, ME Miller, G Russell, and M Mauer Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes Diabetes 51 2002 506 513
91. S Krag, JR Nyengaard, and L Wogensen Combined effects of moderately elevated blood glucose and locally produced TGF-beta1 on glomerular morphology and renal collagen production Nephrol Dial Transplant 22 2007 2485 2496
92. H Trachtman, FC Fervenza, DS Gipson, P Heering, DR Jayne, H Peters, S Rota, G Remuzzi, LC Rump, LK Sellin, JP Heaton, JB Streisand, ML Hard, SR Ledbetter, and F Vincenti A phase 1, single-dose study of fresolimumab, an anti-TGF-beta antibody, in treatment-resistant primary focal segmental glomerulosclerosis Kidney Int 79 2011 1236 1243
93. X Yang, JJ Letterio, RJ Lechleider, L Chen, R Hayman, H Gu, AB Roberts, and C Deng Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta EMBO J 18 1999 1280 1291
94. EC Connolly, J Freimuth, and RJ Akhurst Complexities of TGF-beta targeted cancer therapy Int J Biol Sci 8 2012 964 978
95. Riser BL, Cortes P, DeNichilo M, Deshmukh PV, Chahal PS, Mohammed AK, Yee J, Kahkonen D: Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: preliminary report. Kidney Int 64:451-458, 2003
96. SG Adler, S Schwartz, ME Williams, C Arauz-Pacheco, WK Bolton, T Lee, D Li, TB Neff, PR Urquilla, and KL Sewell Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria Clin J Am Soc Nephrol 5 2010 1420 1428
97. M Kurdián, I Herrero-Fresneda, N Lloberas, P Gimenez-Bonafe, V Coria, MT Grande, J Boggia, L Malacrida, J Torras, MA Arévalo, F González-Martínez, JM López-Novoa, J Grinyó, and O Noboa Delayed mTOR inhibition with low dose of everolimus reduces TGFbeta expression, attenuates proteinuria and renal damage in the renal mass reduction model PLoS ONE 7 2012 e32516
98. Akhmetshina A, Palumbo K, Dees C, Bergmann C, Venalis P, Zerr P, Horn A, Kireva T, Beyer C, Zwerina J, Schneider H, Sadowski A, Riener MO, MacDougald OA, Distler O, Schett G, Distler JH: Activation of canonical Wnt signaling is required for TGF-beta-mediated fibrosis. Nat Commun 3:735. http://dx.doi.org/10. 1038/ncomms1734:735, 2012
99. S Hao, W He, Y Li, H Ding, Y Hou, J Nie, FF Hou, M Kahn, and Y Liu Targeted inhibition of {beta}-catenin/CBP signaling ameliorates renal interstitial fibrosis J Am Soc Nephrol 22 2011 1642 1653
100. WR Henderson Jr, EY Chi, X Ye, C Nguyen, YT Tien, B Zhou, Z Borok, DA Knight, and M Kahn Inhibition of Wnt/beta-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis Proc Natl Acad Sci U S A 107 2010 14309 14314
101. J Mann, and DA Mann Epigenetic regulation of wound healing and fibrosis Curr Opin Rheumatol 25 2013 101 107
102. S Putta, L Lanting, G Sun, G Lawson, M Kato, and R Natarajan Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy J Am Soc Nephrol 23 2012 458 469